{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:27:38Z","timestamp":1793406458342,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107630","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:41:22Z","timestamp":1758584482000},"page":"107630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epidemiology, treatment and outcomes of bloodstream infections due to MBL-producing Enterobacterales in France: A retrospective study"],"prefix":"10.1016","volume":"66","author":[{"given":"Beno\u00eet","family":"Pilmis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6596-7384","authenticated-orcid":false,"given":"Laurent","family":"Dortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107630_bib0001","article-title":"The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","author":"Hatim","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107630_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijantimicag.2018.05.010","article-title":"The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy","volume":"52","author":"Menichetti","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"10325","key":"10.1016\/j.ijantimicag.2025.107630_bib0003","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107630_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107630_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.ijantimicag.2025.107630_bib0006","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2025.107630_bib0007","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.ijantimicag.2025.107630_bib0008","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative Bacilli: results from a nationwide study in Italy (ALARICO Network)","volume":"76","author":"Falcone","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0009","unstructured":"Bilan d'activit\u00e9 2022 du CNR de la R\u00e9sistance aux Antibiotiques. www.cnr-resistance-antibiotiques.fr\/ressources\/pages\/CNR_bilan_2022.pdf. (Accessed October 6, 2025)."},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0010","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107630_bib0011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"19","key":"10.1016\/j.ijantimicag.2025.107630_bib0012","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.19.2300209","article-title":"Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union\/European Economic Area, 2012 to June 2022","volume":"28","author":"Linkevicius","year":"2023","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107630_bib0013","doi-asserted-by":"crossref","first-page":"dlae141","DOI":"10.1093\/jacamr\/dlae141","article-title":"Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline","volume":"6","author":"Haidar","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107630_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkae393","article-title":"Global emergence of Escherichia coli with PBP3 insertions","volume":"80","author":"Long","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.ijantimicag.2025.107630_bib0015","first-page":"1877","article-title":"Population analysis of Escherichia coli sequence type 361 and reduced cefiderocol susceptibility, France","volume":"29","author":"Jousset Agn\u00e8s","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.ijantimicag.2025.107630_bib0016","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/jac\/dku105","article-title":"The Balkan region: nDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece","volume":"69","author":"Evangelia","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107630_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123337","article-title":"Nosocomial outbreak of New Delhi metallo-\u03b2-lactamase-1-producing gram-negative bacteria in South Africa: a case-control study","volume":"10","author":"de Jager","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jhin.2023.04.016","article-title":"Trends in hospital acquired New Delhi metallo-beta-lactamase-producing enterobacterales in Tuscany (Italy) from 2019 to 2021: impact of the COVID-19 pandemic","volume":"137","author":"Arzilli","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0019","unstructured":"Surveillance Definitions, 2025. www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf. (accessed July 2, 2025)"},{"issue":"8","key":"10.1016\/j.ijantimicag.2025.107630_bib0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mic.2002.129427","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"30","author":"O\u2019Grady","year":"2002","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107630_bib0021","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","article-title":"Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"22","author":"Falcone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0022","series-title":"Antimicrobial resistance surveillance in Europe2022: 2020 data","year":"2022"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0023","series-title":"Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation - 2020","year":"2020"},{"issue":"7","key":"10.1016\/j.ijantimicag.2025.107630_bib0024","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/microorganisms13071697","article-title":"Global epidemiology and Antimicrobial resistance of Klebsiella Pneumoniae carbapenemase (KPC)-producing gram-negative clinical isolates: a review","volume":"13","author":"Falagas","year":"2025","journal-title":"Microorganisms"},{"issue":"10325","key":"10.1016\/j.ijantimicag.2025.107630_bib0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"Pt 5","key":"10.1016\/j.ijantimicag.2025.107630_bib0026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1099\/jmm.0.071340-0","article-title":"Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test","volume":"63","author":"Dortet","year":"2014","journal-title":"J Med Microbiol"},{"issue":"42","key":"10.1016\/j.ijantimicag.2025.107630_bib0027","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.42.2300095","article-title":"Emergence and rapid dissemination of highly resistant NDM-14-producing Klebsiella pneumoniae ST147, France, 2022","volume":"28","author":"Emeraud","year":"2023","journal-title":"Eurosurveillance"},{"issue":"7","key":"10.1016\/j.ijantimicag.2025.107630_bib0028","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jac\/dkad149","article-title":"Performance evaluation of the UMIC\u00ae Cefiderocol to determine MIC in gram-negative bacteria","volume":"78","author":"Dortet","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0029","unstructured":"European Commitee of Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints and dosing of antibiotics. Available at: http:\/\/www.eucast.org\/clinical_breakpoints\/, (Accessed October 2, 2019)."},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107630_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106563","article-title":"High prevalence of cefiderocol resistance in carbapenem-resistant Escherichia coli: a warning from multicenter clinical data in China","volume":"91","author":"Lu","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2025.107630_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-025-05166-w","article-title":"Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolates","author":"Sadek","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107630_bib0032","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5005\/jp-journals-10071-24876","article-title":"Clinical predispositions, features, and outcomes of infections with carbapenem-resistant enterobacterales among Critical Care patients","volume":"29","author":"Shoala","year":"2025","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107630_bib0033","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciad725","article-title":"Clinical features and outcomes of infections caused by metallo-\u03b2-lactamase\u2013Producing enterobacterales: a 3-year prospective study from an endemic area","volume":"78","author":"Falcone","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107630_bib0034","doi-asserted-by":"crossref","first-page":"298.e1","DOI":"10.1016\/j.cmi.2021.06.031","article-title":"Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)","volume":"28","author":"Falcone","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.ijantimicag.2025.107630_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01090-24","article-title":"Detection of cefiderocol and aztreonam\/avibactam resistance in epidemic Escherichia coli ST-361 carrying blaNDM-5 and blaKPC-3 from foreign fighters evacuated from Ukraine","volume":"68","author":"Martin","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107630_bib0036","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jac\/dkz468","article-title":"In vitro selection of aztreonam\/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae","volume":"75","author":"Niu","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2025.107630_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107630_bib0038","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciad725","article-title":"Clinical features and outcomes of infections caused by metallo-\u03b2-lactamase-producing enterobacterales: a 3-year prospective study from an endemic area","volume":"78","author":"Falcone","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijantimicag.2025.107630_bib0039","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/cid\/ciac082","article-title":"Cefiderocol for the treatment of metallo-\u03b2-lactamases producing gram-negative Bacilli: lights and shadows from the literature","volume":"75","author":"Falcone","year":"2022","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:09:49Z","timestamp":1775516989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001852"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107630","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, treatment and outcomes of bloodstream infections due to MBL-producing Enterobacterales in France: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107630"}}